We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 568 results
  1. Application of comprehensive unit-based safety program model to improve chemotherapy-induced nausea and vomiting in patients with ovarian cancer: a retrospective study

    Background

    To explore the effect of intervention programs constructed under the guidance of the comprehensive unit-based safety program (CUSP) model...

    Aihua Liu, Min Li, ... Jie Yang in Journal of Ovarian Research
    Article Open access 20 July 2023
  2. Effects of different auricular point therapies on digestive symptoms and quality of life in patients undergoing platinum-based chemotherapy

    Objective

    To compare the effects of auricular point intradermal needling with auricular point sticking on digestive symptoms and quality of life in...

    Yanyan He, Zhiling Sun, ... Jiawei Li in Journal of Acupuncture and Tuina Science
    Article 27 October 2023
  3. Characteristics of nausea and its impact on health-related quality of life in cisplatin-treated patients receiving dexamethasone-sparing prophylaxis: an analysis of the LUNG-NEPA study

    Purpose

    We investigated the intensity and duration of nausea as well as its impact on health-related quality of life among cisplatin-treated patients...

    Luigi Celio, Matti Aapro in Supportive Care in Cancer
    Article 04 March 2024
  4. Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study

    Objective

    A prospective randomized controlled trial was conducted to compare 5 mg olanzapine plus standard triple antiemetic therapy for the...

    Jiali Gao, Jun Zhao, ... Quanfu Li in Supportive Care in Cancer
    Article Open access 21 April 2022
  5. The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer

    Purpose

    To evaluate the efficacy of aprepitant and its effect on the quality of life when added to standard antiemetic therapy as salvage therapy.

    ...
    Qiaoyan Gong, Jiangfang Tian, ... Dan Cao in International Journal of Clinical Oncology
    Article 22 March 2021
  6. Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature

    Purpose

    Cisplatin-based chemoradiotherapy (CRT) is standard treatment for head and neck squamous cell carcinoma (HNSCC). However, IMRT may increase...

    Carlotta Becherini, Viola Salvestrini, ... Pierluigi Bonomo in La radiologia medica
    Article Open access 14 February 2024
  7. Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients

    Purpose

    The purpose of the present prospective study was to evaluate the significance of geriatric conditions measured by a comprehensive geriatric...

    Katarzyna Paal, Bettina Stranz, ... Tanja Langsenlehner in Strahlentherapie und Onkologie
    Article Open access 02 September 2023
  8. Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting

    Purpose

    Neurokinin 1 receptor antagonists included prophylactic treatment was recommended for patients who receive one-day cisplatin chemotherapy. It...

    Yanying Li, Yuming Wan, ... Jiang Zhu in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 June 2024
  9. Quality of life issues in patients with bone metastases: A systematic review

    Introduction

    Bones are frequent sites of metastatic disease, observed in 30–75% of advanced cancer patients. Quality of life (QoL) is an important...

    Thenugaa Rajeswaran, Henry C. Y. Wong, ... Edward Chow in Supportive Care in Cancer
    Article 13 December 2023
  10. Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial

    Background We examined the efficacy of mirtazapine in preventing delayed nausea and vomiting following highly emetogenic chemotherapy (HEC). Patients...

    Jun Cao, Quchang Ouyang, ... **chun Hu in Investigational New Drugs
    Article 08 February 2020
  11. Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective

    Purpose

    The aim of this study was to assess the cost-effectiveness of NEPA, a fixed-dose combination of oral netupitant (300 mg) and palonosetron...

    Jonas Nilsson, Vittoria Piovesana, ... Matti Aapro in Supportive Care in Cancer
    Article Open access 08 September 2022
  12. Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial

    Background

    There is sparse research reporting effective interventions for preventing nausea and emesis caused by concurrent chemoradiotherapy (CCRT)...

    Zekun Wang, Wenyang Liu, ... Ye Zhang in Strahlentherapie und Onkologie
    Article 30 May 2022
  13. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer

    Background

    Gastrointestinal symptoms are common in patients with cancer, whether related to treatment or a direct effect of the disease itself....

    Bryony Alderman, David Hui, ... Mellar Davis in Supportive Care in Cancer
    Article 16 December 2022
  14. Paediatric hydrocephalus

    Hydrocephalus is classically considered as a failure of cerebrospinal fluid (CSF) homeostasis that results in the active expansion of the cerebral...

    Kristopher T. Kahle, Petra M. Klinge, ... Jennifer M. Strahle in Nature Reviews Disease Primers
    Article 16 May 2024
  15. Luminal Gastrointestinal Manifestations of Cystic Fibrosis

    Purpose of Review

    People with cystic fibrosis (CF) are living longer. General age-related and CF-specific gastrointestinal symptoms are increasingly...

    Samuel J Burton, Christine Hachem, James M. Abraham in Current Gastroenterology Reports
    Article 23 March 2021
  16. A Tailored Approach to Laparoscopic Fundoplication: Outcomes in Patients with Esophageal Dysmotility

    Background

    Esophageal dysmotility is a common finding in patients being evaluated for antireflux surgery, although its implication remains unclear. We...

    Harry J. Wong, Mason Vierra, ... Michael B. Ujiki in Journal of Gastrointestinal Surgery
    Article 11 October 2022
  17. A prospective randomized controlled clinical trial investigating the efficacy of low-dose olanzapine in preventing nausea and vomiting associated with oxaliplatin-based and irinotecan-based chemotherapy

    Objective

    The aim of this study is to assess the clinical efficacy of a 5 mg dosage of olanzapine in preventing chemotherapy-induced nausea and...

    **g Shen, Juan Zhao, ... Quanfu Li in Journal of Cancer Research and Clinical Oncology
    Article Open access 28 May 2024
  18. Significant changes in impedance planimetry (EndoFLIP™) measurements after peroral pyloromyotomy for delayed gastric emptying

    Background

    The endoluminal functional lumen imaging probe (FLIP) can be used to obtain real-time measurements of the diameter ( D min ), cross-sectional...

    Mikhail Attaar, Bailey Su, ... Michael B. Ujiki in Surgical Endoscopy
    Article 19 March 2021
  19. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients

    Purpose

    Olanzapine-containing regimens have been reported to be effective in preventing CINV following highly emetogenic chemotherapy (HEC), but it is...

    Ronald Chow, Leonard Chiu, ... Rudolph M. Navari in Supportive Care in Cancer
    Article 07 January 2021
  20. Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences

    The treatment landscape for gastric cancer (GC) is constantly evolving with therapies affecting all aspects of health-related quality of life (HRQoL)...

    Alison Rowsell, Samantha C. Sodergren, ... Mitsumi Terada in Gastric Cancer
    Article Open access 11 June 2022
Did you find what you were looking for? Share feedback.